Overview
Gaurav Bahl practices practicing medicine in Abbotsford, Canada.
His clinical expertise encompasses Squamous Cell Skin Carcinoma, Basal Cell Skin Cancer, and Melanoma.
He is actively involved in clinical research, co-authoring 10 peer reviewed articles.
Gender
Locations
Abbotsford, BC, Canada
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Gaurav Bahl
Is Gaurav Bahl a top-rated expert for Squamous Cell Skin Carcinoma?
MediFind is an objective health platform that identifies experts based on real-world data. Gaurav Bahl is classified as an Experienced expert for Squamous Cell Skin Carcinoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Gaurav Bahl participate in research or clinical trials?
Yes. Gaurav Bahl has published 10 articles and abstracts on conditions like Squamous Cell Skin Carcinoma. You can view a list of Gaurav Bahl's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Basal Cell Skin CancerMr. Bahl isExperienced. Learn about Basal Cell Skin Cancer.
- MelanomaMr. Bahl isExperienced. Learn about Melanoma.
- Squamous Cell Skin CarcinomaMr. Bahl isExperienced. Learn about Squamous Cell Skin Carcinoma.